Pfizer in 2005

            
 
Case Studies | Case Study in Business, Management, Operations, Strategy, Case Study

ICMR HOME | Case Studies Collection

To download Pfizer in 2005 case study (Case Code: BSTA120) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies


OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here


Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Area Specific Case Studies
Industry Wise Case Studies
Company Wise Case Studies

Custom Search



Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

Case Details:

Price:

Case Code : BSTA120 Electronic Format: Rs. 300;
Courier (within India):Rs. 25 Extra
Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Themes

-
Case Length : 15 Pages
Period : 1849-2005
Organization : -
Pub Date : 2005
Teaching Note : Not Available
Countries : USA
Industry : Pharmaceuticals

Abstract:

The world's largest research-based pharmaceuticals firm, Pfizer is well known for its blockbuster drugs such as the pain management drug Celebrex, erectile dysfunction therapy Viagra, and cholesterol-lowering Lipitor. Pfizer's biggest challenge currently is patent expiration. The company has already warned investors it will probably lose some $14 billion due to patent expirations by 2007. Besides, the sales of some of Pfizer's blockbuster drugs such as Viagra and Lipitor are declining due to intensifying competition from other drug makers. Pfizer is also moving in a direction that will pit it against biotech companies such as Onyx, Genentech. Will Pfizer be able to find alternative sources of revenue? Will Pfizer's forays into biotech succeed?

Contents:

  Page No.
Introduction 1
Background Note 1
Business 2
Packaging 3
Hitting the Big League 4
Acquisitions 5
Growing Concerns 7
The Road Ahead 10
Exhibits 11

Keywords:

Pfizer, research-based pharmaceuticals firm, pain management drug Celebrex, Viagra, Lipitor, Pfizer's patent expiration, Pfizer's blockbuster drugs and Pfizer's forays into biotec

Pfizer in 2005 - Next Page>>


Custom Search





Economics for Managers Textbook
Textbooks Collection

Economics for Managers Workbook
ICMR books Collection

Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.